CANC
GILD icon

Culbertson A N & Co’s Gilead Sciences GILD Stock Holding History

Culbertson A N & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,875
Closed -$219K – 85
2015
Q2 		$219K Buy
+1,875
New +$205K 0.09% 81

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Culbertson A N & Co's GILD Position: Q3 2015 in Review

Culbertson A N & Co sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 1,875 shares — an estimated $219K sold.

Culbertson A N & Co first reported a position in GILD in Q2 2015 and held it in 1 quarter. The position peaked at $219K in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Culbertson A N & Co reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • Culbertson A N & Co sold 1,875 Gilead Sciences shares in Q3 2015, an estimated $219K.
  • Culbertson A N & Co first reported a position in Gilead Sciences in Q2 2015 and held it in 1 quarter.
  • Culbertson A N & Co's Gilead Sciences position peaked at $219K in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Culbertson A N & Co's 13F filing for Q3 2015, filed 16 Oct 2015.